Release Date: 17/03/09 10:18 Summary: Everest Masters Fund II Update Price Sensitive: No Download Document 27.27KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%